glp-1 prescriptions q1 2025 GLP1s: Today's the worst it will ever be, it's only up from here GLP-1 Antagonists Increase Plan Drug

This is not a single-target drug

Commonly used for managing type 2 diabetes and aiding weight loss in overweight or obese individuals, GLP-1 drugs offer additional benefits like potential cardiovascular protection for diabetic patients

Protection against stroke with glucagon-like peptide-1 receptor agonists: A comprehensive review of potential mechanisms

The main adverse effects leading to drug discontinuation were gastrointestinal disorders

Results: No glucose infusion was required in lean subjects to sustain euglycemia (glucose clamp) during saline or GLP-1m infusions

[DOI] [PMC free article] [PubMed] [Google Scholar] 18.Hernandez A.F., Green J.B., Janmohamed S., DAgostino R.B., Granger C.B., Jones N.P., Leiter L.A., Rosenberg A.E., Sigmon K.N., Somerville M.C., et al